BioStable

About:

BioStable is a cardiovascular device company that develops innovative new products for the treatment of cardiovascular diseases.

Website: http://www.biostable-s-e.com

Twitter/X: discoverhaart

Top Investors: Sante Ventures, Orlando Health Ventures, Solas BioVentures, Rex Health Ventures, Longmeadow Capital Partners

Description:

BioStable is a cardiovascular device company that develops innovative new products for the treatment of cardiovascular diseases. The company is led by an experienced group of industry executives with expertise in rapid and effective medical device development. The organization incorporates core strengths in all areas of product development including quality systems, design, engineering, prototyping and pilot production, in-vitro and in-vivo testing, manufacturing, global regulatory relationships, clinical product validation, market launch, and distribution. BioStable provides a competitive edge by minimizing time to market for cost-effective medical devices that deliver improved clinical outcomes. The company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. BioStable was founded in

Total Funding Amount:

$10.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Austin, Texas, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)biostable-s-e.com

Founders:

Al Beavan, Don James, J. Scott Rankin, Rusty Phillips

Number of Employees:

1-10

Last Funding Date:

2020-02-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai